Advertisement

Biologics licence application News

alt
Drug major Sun Pharmaceutical Industries on Wednesday said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis.






Loading...
english news
NEWS ON ONE CLICK